Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Deciphera Pharmaceuticals Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $172 million public offering of common stock…
Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $2.05 Billion Refinancing
Davis Polk advised Valeant Pharmaceuticals International, Inc. in connection with a refinancing transaction pursuant to…
Valeant Pharmaceuticals International $4.565 Billion Term Loan Facility and $1.225 Billion Revolving Credit Facility
Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) and Valeant Pharmaceuticals International in…
Iterum Therapeutics plc Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with Iterum Therapeutics plc’s initial…
Melinta Therapeutics, Inc. Common Stock Offering
Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 24,640,000…
Ardelyx, Inc. $50 Million Public Offering
Davis Polk advised the joint book-running managers for a $50 million public offering of common stock by Ardelyx, Inc…
Coherus BioSciences, Inc. $86.25 Million Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $86.25 million public offering of common…
AbbVie Inc. $3 Billion 364-Day Term Loan Credit Facility
Davis Polk advised the lenders in connection with a $3 billion 364-day term loan credit facility for AbbVie Inc. …
Calyxt, Inc. Common Stock Offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 4…
Davis Polk Advises Shire on Its Proposed Acquisition by Takeda
Davis Polk, together with Slaughter and May, is advising Shire plc in connection with a recommended cash and stock offer for…